Home / Going-concern warnings / Iterum Therapeutics plc
Filed 2025-05-13 · Form 10-Q · Accession 0000950170-25-069802 nano
Price before filing: $1.01 (2025-05-12 close, split/dividend-adjusted)
Market cap at flag: $32.0M (2025-05-13) · Latest: $851,916 (2026-04-27)
| Window | ITRM | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -1.4% | +3.6% | -4.9% | 2025-06-12 |
| 90 days | -29.3% | +9.4% | -38.7% | 2025-08-11 |
| 180 days | -40.7% | +17.6% | -58.3% | 2025-11-10 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"These risks include the following: • We have identified conditions and events that raise substantial doubt about our ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-03-31)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Newsletter delivered by beehiiv. See our privacy policy.